BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18522229)

  • 1. Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients.
    Ferrero I; Mazzini L; Rustichelli D; Gunetti M; Mareschi K; Testa L; Nasuelli N; Oggioni GD; Fagioli F
    Cell Transplant; 2008; 17(3):255-66. PubMed ID: 18522229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow.
    Mareschi K; Ferrero I; Rustichelli D; Aschero S; Gammaitoni L; Aglietta M; Madon E; Fagioli F
    J Cell Biochem; 2006 Mar; 97(4):744-54. PubMed ID: 16229018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis.
    Choi MR; Kim HY; Park JY; Lee TY; Baik CS; Chai YG; Jung KH; Park KS; Roh W; Kim KS; Kim SH
    Neurosci Lett; 2010 Mar; 472(2):94-8. PubMed ID: 20117176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell treatment in Amyotrophic Lateral Sclerosis.
    Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Nasuelli N; Oggioni GD; Testa L; Fagioli F
    J Neurol Sci; 2008 Feb; 265(1-2):78-83. PubMed ID: 17582439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human multipotent mesenchymal stromal cells from fetal lung expressing pluripotent markers and differentiating into cell types of three germ layers.
    Zheng C; Yang S; Guo Z; Liao W; Zhang L; Yang R; Han ZC
    Cell Transplant; 2009; 18(10):1093-109. PubMed ID: 19650974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells.
    Lo Surdo J; Bauer SR
    Tissue Eng Part C Methods; 2012 Nov; 18(11):877-89. PubMed ID: 22563812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory Properties of Bone Marrow Mesenchymal Stem Cells from Patients with Amyotrophic Lateral Sclerosis and Healthy Donors.
    Javorkova E; Matejckova N; Zajicova A; Hermankova B; Hajkova M; Bohacova P; Kossl J; Krulova M; Holan V
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):215-225. PubMed ID: 30242613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells.
    Redaelli S; Bentivegna A; Foudah D; Miloso M; Redondo J; Riva G; Baronchelli S; Dalprà L; Tredici G
    Stem Cell Res Ther; 2012 Nov; 3(6):47. PubMed ID: 23168092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation potential of bone marrow mesenchymal stem cells in duck.
    Li L; Bai X; Gong X; Liu H; Chen L; Guan W; Ma Y
    J Genet Genomics; 2009 Mar; 36(3):133-40. PubMed ID: 19302969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, characterization and neural differentiation potential of amnion derived mesenchymal stem cells.
    Manochantr S; Tantrawatpan C; Kheolamai P; U-pratya Y; Supokawej A; Issaragrisil S
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S183-91. PubMed ID: 21294413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro.
    Yang YK; Ogando CR; Wang See C; Chang TY; Barabino GA
    Stem Cell Res Ther; 2018 May; 9(1):131. PubMed ID: 29751774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects "stemness" properties.
    Bakopoulou A; Apatzidou D; Aggelidou E; Gousopoulou E; Leyhausen G; Volk J; Kritis A; Koidis P; Geurtsen W
    Stem Cell Res Ther; 2017 Nov; 8(1):247. PubMed ID: 29096714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue.
    Rebelatto CK; Aguiar AM; Moretão MP; Senegaglia AC; Hansen P; Barchiki F; Oliveira J; Martins J; Kuligovski C; Mansur F; Christofis A; Amaral VF; Brofman PS; Goldenberg S; Nakao LS; Correa A
    Exp Biol Med (Maywood); 2008 Jul; 233(7):901-13. PubMed ID: 18445775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Age-related biological characteristics of human bone marrow mesenchymal stem cells from different age donors].
    Huang K; Zhou DH; Huang SL; Liang SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1049-53. PubMed ID: 16403278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of mesenchymal stem cells from patients with amyotrophic lateral sclerosis.
    Matejckova N; Zajicova A; Hermankova B; Kossl J; Bohacova P; Holan V; Javorkova E
    J Clin Pathol; 2018 Aug; 71(8):735-742. PubMed ID: 29523587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.
    Bernardo ME; Zaffaroni N; Novara F; Cometa AM; Avanzini MA; Moretta A; Montagna D; Maccario R; Villa R; Daidone MG; Zuffardi O; Locatelli F
    Cancer Res; 2007 Oct; 67(19):9142-9. PubMed ID: 17909019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
    Isaikina Y; Kustanovich A; Svirnovski A
    Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identity, proliferation capacity, genomic stability and novel senescence markers of mesenchymal stem cells isolated from low volume of human bone marrow.
    Kundrotas G; Gasperskaja E; Slapsyte G; Gudleviciene Z; Krasko J; Stumbryte A; Liudkeviciene R
    Oncotarget; 2016 Mar; 7(10):10788-802. PubMed ID: 26910916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow donor selection and characterization of MSCs is critical for pre-clinical and clinical cell dose production.
    Trivedi A; Miyazawa B; Gibb S; Valanoski K; Vivona L; Lin M; Potter D; Stone M; Norris PJ; Murphy J; Smith S; Schreiber M; Pati S
    J Transl Med; 2019 Apr; 17(1):128. PubMed ID: 30995929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.